Adjuvant denosumab in early breast cancer

Lancet Oncol. 2020 Mar;21(3):e121. doi: 10.1016/S1470-2045(20)30001-2.

Authors

Niamh Peters¹, Michael Conroy², Seamus O'Reilly²

Affiliations

¹ Department of Medical Oncology, Cork University Hospital, Wilton, Cork T12DC4A, Ireland. Electronic address: niamhpeters27@gmail.com.
² Department of Medical Oncology, Cork University Hospital, Wilton, Cork T12DC4A, Ireland.

PMID: 32135105
DOI: 10.1016/S1470-2045(20)30001-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Aromatase Inhibitors
Bone Density Conservation Agents*
Denosumab*

Substances

Aromatase Inhibitors
Bone Density Conservation Agents
Denosumab